Basilea Pharmaceutica AG

Basilea Pharmaceutica AG

Basilea Pharmaceutica AG

Overview
Date Founded

2002

Headquarters

Grenzacherstrasse 487, Basel, 4058, CHE

Type of Company

Public

Employees (Worldwide)

150

Industries

Pharmaceuticals
Biotechnology

Company Description

Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX:BSLN). Through its fully integrated research and development operations the company focuses on the development of innovative antibiotics, antifungals and oncology drugs, targeting the medical challenge of resistance and non-response to current treatment options.

Contact Data
Trying to get in touch with decision makers at Basilea Pharmaceutica AG? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Financial Officer

General Counsel & Corporate Secretary

Chief Technology Officer

Chief Scientific Officer

Chief Medical Officer

Head of Global Human Resources

Head of Global Quality Management

Vice Chairman

Board of Directors

President at I-Net Innovation Networks

Senior Vice President at GlaxoSmithKline Plc

Former Executive Chairman at Orexo AB

Global Head-Clinical & Data Operations at Quintiles Transnational Corp.

Former Director at Basilea Pharmaceutica AG

Director at Basilea Pharmaceutica AG

Paths to Basilea Pharmaceutica AG
Potential Connections via
Relationship Science
You
Basilea Pharmaceutica AG
Owners & Shareholders
Details Hidden

Privus AG is a Swiss private company located in Zurich. The firm provides investment advice. It was founded in 2009 by Thomas Flothen, he has been the CEO since the inception date.

Details Hidden

Maiestas Asset Management seeks to preserve their clients’ wealth by developing individual strategy based on their personal circumstances.

Details Hidden

Rüetschi Zehnder AG is a Swiss private company located in Frick. The firm provides investment advice. It was founded in 1996 by Anton Rüetschi. Lukas Rüetschi has been the CEO since 1998.

Recent Transactions
Details Hidden

Basilea Pharmaceutica AG issued CHF Ordinary Shares

Transaction Advisors
Underwriter

Advised onBasilea Pharmaceutica AG issued CHF Ordinary Shares

Auditor

Advised onBasilea Pharmaceutica AG issued CHF Ordinary Shares

Clients

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Hikma Pharmaceuticals We are committed to improving people’s lives. Through our existing products and pending approvals across our markets, our aim is to provide patients with better access to high-quality, cost-effective medicines in key therapeutic areas. Our vision Our vision is to build Hikma into a world class and leading specialty pharmaceutical company, with presence across the globe. Through organic growth and by acquisitions which are aligned with our strategy, we will continue to develop the business and maintain the high standards of ethics and responsibility which are central to the way we operate.

Key Stats and Financials As of 2020
Market Capitalization
$603M
Total Enterprise Value
$642M
Earnings Per Share
$-1.48
Enterprise Value / Sales
4.87x
TEVNet Income
-42.22x
Debt TEV
0.39x
EBITDAMargin
-16.43%
Three Year Compounded Annual Growth Rate Of Revenue
7.93%
Revenue
$132M
Net Profit
$-15.2M
EBITDA
$-21.7M
Total Debt
$250M
Total Equity
$-105M
Suppliers
Cancer Research UK Hospitals & Patient Services | London, United Kingdom

Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.

ArQule, Inc. Pharmaceuticals | Woburn, MA

ArQule, Inc. is a biopharmaceutical company. It engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA.

Merck & Co., Inc. Medical Support Services | Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Basilea Pharmaceutica AG. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Basilea Pharmaceutica AG's profile does not indicate a business or promotional relationship of any kind between RelSci and Basilea Pharmaceutica AG.